Delivery Order SPE2DB22D3501-SPE2DB23FWN76
Award Date 7/24/23
Potential Completion Date 7/25/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,748.30 to AmerisourceBergen Drug Corp for FORTEO 560 micrograms per 2.24 milliliter pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of October 27, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for FORTEO 560 mcg/2.24 mL pen injections (2.24 mL). The contract, which carries no set-aside designation, was competitively awarded on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. FORTEO is a brand-name pharmaceutical product used in the treatment of...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The Defense Logistics Agency awarded a $12,869.67 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections), a brand-name pharmaceutical product used in osteoporosis treatment. The contract is a firm fixed-price delivery order with an ultimate completion date of May 19, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,993.09 to AmerisourceBergen Drug Corp for FORTEO (forteoide) 560 micrograms per 2.24 milliliters pen injections on August 19, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $5,175.77 to Amerisourcebergen Drug Corporation for the provision of FORTEO 600 MCG/2.4 ML pen injections. The single day order is for the delivery of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from August 30 through August 31, 2023. No major subcontractors or set aside designations were indicated. The Defense...
- The Defense Logistics Agency awarded a $5,202.86 delivery order to AmerisourceBergen Drug Corp for FORTEO (generic name: teriparatide) 560 MCG/2.24 ML pen injections on June 6, 2025, with completion scheduled for June 9, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. FORTEO is a prescription medication used to treat osteoporosis in patients at high risk for fractures, representing a specialized...
- The Defense Logistics Agency awarded a $11,376.94 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections) on December 3, 2025, with completion by December 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,711.38 to AmerisourceBergen Drug Corp for the supply of FORTEO (560 mcg/2.24 ml pen injections). This non-set-aside, firm fixed-price delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $19,378.19 delivery order to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, which utilized no set-aside designation, was issued under a firm fixed-price contract structure and represents a single delivery order for pharmaceutical supplies to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. FORTEO is a bone-building...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWN76Delivery Order
The Defense Logistics Agency awarded a $10,632 delivery order to Amerisourcebergen Drug Corporation for FORTEO 600 MCG/2.4 ML pen injections. The delivery order is to provide 2.4mL of FORTEO, a drug used to treat osteoporosis, from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer. The firm fixed price order is for a single day's supply and was awarded utilizing an existing DLA-wide contract vehicle. No set aside provisions or subcontractors are indicated. This order supports the DLA's mission to provide medical supplies and pharmaceuticals to military treatment facilities and beneficiaries.
Generated 12/23/23, 12:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 7/24/23 |